The $3.4 Billion Lesson Pharma Faces in Shelved Drugs
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Redeeming credit card points can be tricky. Discover what to avoid to ensure you make the most out of your rewards and benefits.
19,422 articlesThousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Investors chase $100,000 a year in dividend income, but the required capital hinges on yield and payout durability in...
Iran warns that tourist and recreation sites worldwide could be targets as U.S.-Israeli strikes press Tehran’s leader...
A veteran figure in AI, nicknamed the 'godfather ai,' argues big tech prioritizes short-term profits over the endgame...
TRX Gold aims to outpace the market through Buckreef’s expansion and higher gold prices. This guide breaks down the k...
A fresh flare in Middle East tensions pushes oil prices higher, elevating Russia’s revenue outlook and prompting inve...
Oklo’s latest move—acquiring Atomic Alchemy—signals more than a strategic expansion. This article breaks down what it...
Micron just beat earnings, but the stock didn’t soar. This article breaks down what happened, how AI demand, margins,...
A prominent quadruple amputee cornhole champion has been charged with murder following a fatal confrontation in Maryl...
As biotech earnings season unfolds, Precigen (PGEN) 2025 earnings take center stage. This guide breaks down what to m...
If you’re a retiree with AI stock exposure, you’re not alone. This guide explains how to protect income, rebalance ri...
Netflix shares jumped after price hikes, signaling pricing power in streaming. This in-depth look explains what happe...